SCHEMBL4956384

SCHEMBL4956384

O=Cc1ccc(C=O)cc1.O=Cc1ccc(C=O)cc1

nearest known ligand 0.69

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 4/20 0.69
HSD17B10 Q99714 1/20 0.69
ALDH5A1 P51649 1/20 0.69
ABAT P80404 1/20 0.69
ALDH1A1 P00352 8/20 0.67
KDM4E B2RXH2 3/20 0.58
TYR P14679 1/20 0.58
CYP2A13 Q16696 1/20 0.58
ALDH1A3 P47895 2/20 0.52
ALDH3A1 P30838 1/20 0.52
PTGS2 P35354 1/20 0.50
RAB9A P51151 1/20 0.50
EGFR P00533 1/20 0.50
TRIM24 O15164 1/20 0.50
TRIM33 Q9UPN9 1/20 0.50
STS P08842 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31171 1.00 CYP2A6 (0.69) CYP2A6HSD17B10ALDH5A1ABATALDH1A1
Water SCHEMBL29197442 0.96 CYP2A6 (0.65) CYP2A6HSD17B10ALDH5A1ABATALDH1A1
Hydrochloric Acid SCHEMBL28807787 0.96 CYP2A6 (0.65) CYP2A6HSD17B10ALDH5A1ABATALDH1A1
Formaldehyde SCHEMBL20477527 0.92 CYP2A6 (0.61) CYP2A6HSD17B10ALDH5A1ABATALDH1A1
SCHEMBL25288128 0.89 CYP2A6 (0.58) CYP2A6HSD17B10ALDH5A1ABATALDH1A1
SCHEMBL9004502 0.89 CYP2A6 (0.58) CYP2A6HSD17B10ALDH5A1ABATALDH1A1
SCHEMBL1666706 0.89 CYP2A6 (0.58) CYP2A6HSD17B10ALDH5A1ABATALDH1A1
SCHEMBL4195177 0.89 CYP2A6 (0.58) CYP2A6HSD17B10ALDH5A1ABATALDH1A1
SCHEMBL806367 0.89 CYP2A6 (0.58) CYP2A6HSD17B10ALDH5A1ABATALDH1A1
SCHEMBL4195180 0.89 CYP2A6 (0.58) CYP2A6HSD17B10ALDH5A1ABATALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021117521-A1 ADHESIVE COMPOSITION, RUBBER/ORGANIC FIBER CORD COMPOSITE, AND TIRE 株式会社ブリヂストン 2021-06-17 WO disclosed
WO-2021117520-A1 METHOD FOR PRODUCING ADHESIVE COMPOSITION, RUBBER/ORGANIC FIBER CORD COMPOSITE, AND TIRE 株式会社ブリヂストン 2021-06-17 WO disclosed
CN-106349250-B A kind of compound and its preparation method and application of Selective recognition mercury ion 武汉工程大学 2019-03-08 CN disclosed
CN-106349250-A Compound selectively recognizing mercury ions and preparation method and application thereof 武汉工程大学 2017-01-25 CN disclosed
EP-2537875-A1 NOVEL POLYAZOMETHINE Soken Chemical & Engineering Co., Ltd. (JP) 2012-12-26 EP disclosed
US-7390837-B2 Germicidal compositions containing phenylmalonaldehyde-type compounds, or mixtures of phenylmalonaldehyde-type compounds and phthalaldehydes, and methods of using such compositions for disinfection or sterilization ETHICON, INC. (US) 2008-06-24 US disclosed
US-20050171121-A1 Germicidal compositions containing phenylmalonaldehyde-type compounds, or mixtures of phenylmalonaldehyde-type compounds and phthalaldehydes, and methods of using such compositions for disinfection or sterilization ETHICON, INC. 2005-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171121-A1 Germicidal compositions containing phenylmalonaldehyde-type compounds, or mixtures of phenylmalonaldehyde-type compounds and phthalaldehydes, and methods of using such compositions for disinfection or sterilization APEH, ALPG, DDT CYP2A6 281/4885HSD17B10 473/4885ALDH5A1 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.